Related Experiment Videos
Preclinical and phase I clinical studies with Ckd-602, a novel camptothecin derivative
1CKD Research Institute, CKD Pharmaceutical Corporation, Seoul 152-600, Korea.
Annals of the New York Academy of Sciences
|February 24, 2001
Abstract
No abstract available in PubMed .